EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment

Yana Gvozdeva iD, Radiana Staynova iD

Pharmaceutics · 10.02.2025 · 17 (2) · 226

DOI: 10.3390/pharmaceutics17020226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 10.02.2025. Verfasst von Yana Gvozdeva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBDs), such as ulcerative colitis (UC) or Crohn’s disease, are becoming a growing global problem due to the limitations of current treatments, which fail to address the needs of patients effectively. UC is characterized by the widespread inflammation of the mucosal lining, affecting both the rectum and the entire length of the colon. Over the past forty years, traditional treatments for IBDs have primarily relied on anti-inflammatory drugs and immunosuppressive medications. Treatment could be more effective if drugs could be specifically targeted to act directly on the colon. Conventional drug delivery systems for IBDs encounter numerous challenges on their way to the colon, such as physiological barriers and disease severity. To address these issues, pH-dependent carriers have emerged as a promising advancement, offering a more effective and tolerable treatment for UC. These carriers enable localized, targeted action, reducing side effects and preventing the premature clearance of drugs from inflamed colon tissues. pH-responsive systems are a leading approach for targeted drug release in colitis treatment as they take advantage of the varying pH levels throughout the gastrointestinal tract (GIT). By incorporating pH-sensitive polymers, they ensure drug protection and controlled release in the lower GIT. This review will discuss the advantages and limitations of pH-dependent drug delivery systems for colon-targeted drug delivery.

Schlagwörter

Stichwörter der Autor:innen

colon-targeted drug deliverypH-dependent drug delivery systemspH-responsive polymerspH-sensitive carrierulcerative colitis

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
  • Research Institute, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
  • Department of Organisation and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

ORCID-Profile: Yana Gvozdeva, Radiana Staynova

Zitieren

APA

Gvozdeva, Y., & Staynova, R. (2025). pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment. Pharmaceutics, 17(2), 226. https://doi.org/10.3390/pharmaceutics17020226

Vancouver

Gvozdeva Y, Staynova R. pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment. Pharmaceutics. 2025;17(2):226. doi:10.3390/pharmaceutics17020226

BibTeX
@article{Gvozdeva2025,
  author = {Gvozdeva, Yana and Staynova, Radiana},
  title = {pH-Dependent Drug Delivery Systems for Ulcerative Colitis Treatment},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {226},
  doi = {10.3390/pharmaceutics17020226}
}
Kostenlos starten →